Establishing secure connection…Loading editor…Preparing document…

Healthcare Clinical Trial MOU

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL TRIAL MEMORANDUM OF UNDERSTANDING (MOU)

Parties and Primary Contacts

Sponsor Name:

Phone:    Email:

Site / Institution Name:

Phone:    Email:

Recitals and Study Identification

This Memorandum of Understanding is entered into by Sponsor and Site to document their mutual understanding regarding the conduct of the clinical investigation identified below.

Study Title:

Protocol Number:    Phase:

IND / IDE Number (if applicable):

Purpose and Scope of Work

Purpose: Sponsor will provide the investigational product, protocol, and sponsor oversight necessary to evaluate safety and efficacy under the terms below. Site will conduct the study in accordance with the approved protocol, applicable law, and Good Clinical Practice.

Sponsor Responsibilities

Sponsor shall: supply investigational product and device information; provide protocol and investigational brochures; maintain regulatory filings required by applicable law; monitor study conduct; and provide timely safety information. Sponsor will also provide training to Site personnel as required.

Regulatory Compliance, IRB and Informed Consent

Site shall obtain IRB/EC approval and maintain documentation of informed consent for each participant. Both parties shall cooperate in submission of regulatory and ethics documentation, and in prompt reporting of serious adverse events.

Institutional Review Board / Ethics Committee:    IRB Approval Date:

Privacy, Data Use and HIPAA Compliance

Both parties acknowledge obligations under applicable privacy laws and will ensure confidentiality, secure storage, and limited use of protected health information. Data transfers will be limited to the minimum necessary to achieve the study objectives.

HIPAA Compliance Acknowledgement:  Sponsor and Site represent that they will comply with all applicable privacy and security requirements for protected health information.

Authorization Expiration Date:

Confidentiality, Data Ownership and Publication

Confidential information disclosed under this MOU shall remain the disclosing party's property. The parties agree on limited use for study purposes only and will not disclose confidential information to third parties except as required by law. Data ownership, publication rights, and review periods shall be as set forth below.

Compensation, Costs and Invoicing

Sponsor will reimburse Site in accordance with the payment schedule below. Site will maintain contemporaneous records supporting all invoices and provide invoices in accordance with Sponsor's invoicing procedures.

Total Estimated Budget:

Indemnification and Insurance

Each party shall indemnify and hold harmless the other party for claims arising from its breach of this MOU, negligence, or willful misconduct. Site will carry professional liability insurance adequate for the scope of work.

Term, Termination and Record Retention

Term Start Date:    Estimated End Date:

Termination: Either party may terminate this MOU for material breach with written notice and an opportunity to cure as set out in the formal agreement to follow. Upon termination, both parties shall cooperate to protect participant safety and preserve study data.

Audit, Monitoring and Access to Records

Sponsor and its designees shall have reasonable access to site records and facilities for the purpose of monitoring, auditing, and inspection in accordance with applicable law. Site will permit access to completed case report forms, source records, and regulatory documentation.

Audit Rights Accepted:  Site acknowledges Sponsor audit and monitoring rights under applicable regulations.

Adverse Event Reporting

Phone:    Email:

Phone:    Email:

Representations, Warranties and Governing Law

Each party represents and warrants that it has full authority to enter into this MOU and to perform its obligations. This MOU shall be governed by the laws of the state specified below, without regard to its conflicts of law principles.

Governing Law (State):

Miscellaneous Provisions

This MOU is intended to record the preliminary understanding of the parties and does not create a binding clinical trial agreement for budgeting, indemnity, or other binding obligations except as expressly stated. The parties intend to negotiate and execute a definitive clinical trial agreement covering the full legal terms and financial commitments.

Sponsor Name (Printed):

By (Signature):

Date:

Title / Role:

Site / Institution Name (Printed):

By (Signature):

Date:

Title / Role:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What a Healthcare Clinical Trial MOU Is and when it applies

A Healthcare Clinical Trial MOU (memorandum of understanding) is a written framework that sets out the preliminary terms, roles, and expectations between stakeholders involved in a clinical research collaboration. It typically describes the study scope, responsibilities of sponsor and site, data sharing and privacy obligations, intellectual property considerations, and high-level timelines. An MOU is often nonbinding but can include binding provisions for confidentiality or data handling. It helps align parties during negotiation, supports IRB and contracting workflows, and documents operational arrangements before executing a formal clinical trial agreement.

Why use a Clinical Trial MOU for research partnerships

A clear MOU reduces ambiguity at the start of negotiations, preserves evidence of agreed process steps, and helps sponsors, sites, and CROs coordinate IRB submissions, data use terms, and resource allocation.

Why use a Clinical Trial MOU for research partnerships

Typical parties involved and their roles

Use the MOU to clarify responsibilities before contracting to shorten negotiation cycles and reduce regulatory surprises.

  • Sponsor or biotech company — outlines study design oversight, funding commitments, and data ownership expectations.
  • Site or academic medical center — documents resource contributions, patient population access, and site responsibilities for conduct and reporting.
  • Contract research organization (CRO) or vendor — clarifies operational tasks, monitoring responsibilities, and deliverables during study setup.

Essential sections to include in a professional MOU

A well-structured MOU groups obligations and operational details into clear sections so parties and reviewers (legal, compliance, IRB) can quickly find relevant terms.

Parties

Identify full legal names and roles of each entity, including departmental contacts and authorized signers.

Purpose

Describe the study objective, scope of the collaboration, and high-level deliverables without duplicating protocol text.

Responsibilities

Allocate tasks (study setup, recruitment, monitoring), financial obligations, and milestone ownership between sponsor, site, and CRO.

Data & Privacy

Specify PHI handling, deidentification, data transfer mechanisms, and any required HIPAA Business Associate Agreement (BAA).

Intellectual Property

Define ownership or licensing of study-generated IP, background IP disclosures, and publication rights or review periods.

Termination & Disputes

Set notice periods, interim responsibilities on termination, dispute resolution process, and governing law.

Key required data elements for the MOU

Party Names: Full legal entity names
Authorized Signer: Name and title of signer
Effective Date: MM/DD/YYYY format
Study Identifier: Protocol or internal study ID
Data Contacts: Data custodian and privacy officer
HIPAA Status: BAA required or not

Step-by-step: completing and executing the MOU

Follow these sequential steps to prepare, approve, and sign a clinical trial MOU.

  • 01
    Draft: Assemble standard MOU template and insert study-specific details.
  • 02
    Internal Review: Legal, compliance, and privacy teams review and flag BAAs or technical needs.
  • 03
    Signatory Approval: Obtain OK from authorized signers and budget approvers.
  • 04
    Execute: Exchange signatures and retain executed copy with audit trail.

How to configure an online MOU workflow

Set up a digital workflow that enforces signing order, authentication, and records retention for the executed MOU.

Document Upload Upload the MOU in PDF or DOCX format
Signer Roles Assign sponsor, site, and CRO signer roles
Signing Order Enable sequential or parallel signing per process needs
Authentication Require email link, SMS code, or stronger ID verification
Retention Policy Export signed PDF plus audit trail to secure repository

Digital signing and file format considerations

Ensure the platform can produce a native signed PDF and an unalterable audit report to support compliance reviews.

  • File Types: PDF, DOCX, and editable templates
  • Integrations: Salesforce, NetSuite, Google Workspace
  • Security: TLS in transit and AES-256 at rest

Typical online signing flow for an MOU

A standard e-sign flow streamlines signature capture while preserving evidence needed for audit or regulatory review.

  • Upload Document: Sender uploads final MOU version and adds fields.
  • Assign Signers: Add signer emails and optional roles or authentication.
  • Sign: Each signer reviews and applies signature in sequence.
  • Archive: System stores signed PDF and certificate of completion.

Common timing and deadline checkpoints

Track regulatory and operational deadlines from negotiation through study initiation to avoid start-up delays.

IRB Approval Before Start:

Obtain IRB approval or conditional approval prior to enrolling subjects.

Effective Date:

MOU effective date may precede or follow full contract execution.

Budget & Payment Milestones:

Confirm payment schedule and invoicing triggers before work begins.

Data Transfer Timelines:

Set dates for data handoffs and interim reporting cycles.

Training Completion:

Ensure site staff complete protocol and GCP training prior to enrollment.

Key milestones from negotiation to initiation

A milestone sequence helps stakeholders coordinate approvals and resource allocation toward a single study start date.

01

Negotiation

Clarify scope and financial terms during draft exchange.

02

Internal Approvals

Legal, privacy, and finance sign-off on final text.

03

Signatures

Authorized parties execute the MOU via eSign or wet signature.

04

Study Initiation

Complete IRB and site readiness checks; begin enrollment.

Common mistakes to avoid when preparing an MOU

  • Leaving data handling vague — lack of specifics on transfers, encryption, and retention creates downstream disputes and compliance risk.
  • Skipping internal reviews — not involving legal, compliance, or privacy early causes rework and delayed signatures.
  • Using unsigned templates — circulating inconsistent drafts without version control leads to confusion at execution.
  • Ignoring signatory authority — allowing non‑authorized staff to sign can render agreements unenforceable or require re-execution.

Consequences of errors or noncompliance

HIPAA Violations: Civil and criminal penalties
Regulatory Delay: Study start postponed
Contract Voidability: Signatures challenged
Financial Loss: Sponsor reimbursement disruption
Data Breach Costs: Notification and remediation expenses
Reputational Harm: Institutional trust diminished

Practical examples of how an MOU is used

The following vignettes show typical scenarios where an MOU clarifies responsibilities before a full clinical trial agreement is negotiated.

Academic Site Collaboration

A university research center and sponsor outline preliminary recruitment commitments and budget responsibilities.

  • Streamlined site selection and budgeting.
  • The MOU allowed both parties to confirm feasibility, align timelines, and proceed to a detailed clinical trial agreement with fewer open issues.

Sponsor–CRO Coordination

A small biotech and CRO use an MOU to define milestone ownership and data transfer expectations.

  • Faster operational alignment.
  • With roles and reporting pre-agreed, the organizations completed IRB submissions and system integrations more quickly than with ad hoc negotiations.

eSignature vendor pricing snapshot for MOU workflows

Compare entry-level pricing and feature availability for common eSignature vendors used to execute clinical trial MOUs; signNow appears first per vendor listing requirements.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No envelope cap 100 envelopes/user/year Depends on plan Depends on plan Depends on plan

FAQs and common issues when preparing or signing an MOU

Answers to common questions about enforceability, electronic signatures, HIPAA, signatory authority, and correcting executed MOUs.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.